Abstract
Purpose
The purpose of this study was to systematically assess the efficacy of fish oil therapy on maintenance hemodialysis patients (MHD).
Methods
Electronic databases, including PubMed, Cochrane library, EMBase, and Web of Science, were searched for randomized controlled trials (RCTs) of fish oil versus placebo or no treatment in MHD patients. The study selection and data extraction were conducted independently by two reviewers, and statistical analysis was performed using RevMan software, version 5.2.
Results
A total of thirteen eligible RCTs involving 916 subjects (461 in the experimental group and 455 in the control group) were included. The meta-analysis showed that fish oil significantly reduced arteriovenous graft (AV-graft) events [risk ratio (RR) 0.71, 95 % confidence interval (CI) were (0.52, 0.97)] and cardiovascular events [RR (95 %CI) were 0.41 (0.26, 0.66)] in the fish oil group. In addition, compared with the control group, fish oil significantly decreased the Beck Depression Inventory (BDI) score [weighted mean difference (WMD) (95 %CI) were −11.91 (−15.88, −7.95)], serum intact parathyroidism (iPTH), C-reactive protein (CRP), and triglycerides (TG) [standard mean difference (SMD) (95 %CI) were −0.56 (−0.89, −0.23); −0.36 (−0.63, −0.09), and −0.41 (−0.68, −0.14), respectively]. However, the fish oil group did not differ significantly from the control group in albumin (ALB), hemoglobin (Hb), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-c), and mortality.
Conclusions
Fish oil reduced the risk of AV-graft events and cardiovascular events, and alleviated depression symptoms in MHD patients. It can also improve secondary hyperparathyroidism, micro-inflammation, and hypertriglyceridemia. But there is no evidence that fish oil can improve nutritional status and renal anemia.
Similar content being viewed by others
References
Kalender B, Ozdemir AC, Koroglu G (2006) Association of depression with markers of nutrition and inflammation in chronic kidney disease and end-stage renal disease. Nephron Clin Pract 102:c115–c121
Friedman A, Moe S (2006) Review of the effects of omega-3 supplementation in dialysis patients. Clin J Am Soc Nephrol 47:1064–1071
De Caterina R (2011) n-3 fatty acids in cardiovascular disease. N Engl J Med 364:2439–2450
Cohen SD, Norris L, Acquaviva K et al (2007) Screening, diagnosis, and treatment of depression in patients with end stage renal disease. Clin J Am Soc Nephrol 2:1332–1342
Vernaglione L, Cristofano C, Chimienti S (2008) Omega-3 polyunsaturated fatty acids and proxies of cardiovascular disease in hemodialysis: a prospective cohort study. J Nephrol 21:99–105
Rizos EC, Ntzani EE, Bika E et al (2012) Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA 308(10):1024–1033
Kwak SM, Myung SK, Lee YJ et al (2012) Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials. Arch Intern Med 172(9):686–694
Rasic-Milutinovic Z, Perunicic G, Pljesa S et al (2007) Effects of n-3 PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysispatients. Ren Fail 29:321–329
Bowden RG, Wilson RL, Deike E et al (2009) Fish oil supplementation lowers C-reactive protein levels independent of triglyceride reduction in patients with end-stage renal disease. Nutr Clin Pract 24:508–512
Tayyebi-Khosroshahi H, Houshyar J, Dehgan-Hesari R et al (2012) Effect of treatment with omega-3 fatty acids on C-reactive protein and tumor necrosis factor-alfa in hemodialysis patients. Saudi J Kidney Dis Transpl 23(3):500–506
Perunicic-Pekovic GB, Rasic ZR, Pljesa SI et al (2007) Effect of n-3 fatty acids on nutritional status and inflammatory markers in haemodialysis patients. Nephrology (Carlton) 12:331–336
Noori N, Dukkipati R, Kovesdy CP et al (2011) Dietary omega-3 fatty acid, ratio of omega-6 to omega-3 intake, inflammation, and survival in long-term hemodialysis patients. Am J Kidney Dis 58:248–256
Szklarek-Kubicka M, Fijałkowska-Morawska J, Zaremba-Drobnik D et al (2009) Effect of intradialytic intravenous administration of omega-3 fatty acids on nutritional status and inflammatory response in hemodialysis patients: a pilot study. J Ren Nutr 19(6):487–493
Jadad AR, Moore RA, Carroll D et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1–12
Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M et al (1998) Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 352:609–613
Review Manager (RevMan) [Computer program] (2012) Version 5.2. Copenhagen: the Nordic Cochrane centre, the Cochrane collaboration
Svensson M, Schmidt EB, Jørgensen KA et al (2008) The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study. Nephrol Dial Transplant 23(9):2918–2924
Schmitz PG, McCloud LK, Reikes ST et al (2002) Prophylaxis of hemodialysis graft thrombosis with fish oil: double-blind, randomized, prospective trial. J Am Soc Nephrol 13(1):184–90
Tayebi-Khosroshahi H, Dehgan R, Habibi Asl B et al (2013) Effect of omega-3 supplementation on serum level of homocysteine in hemodialysis patients. Iran J Kidney Dis 7(6):479–84
Saifullah A, Watkins BA, Saha C et al (2007) Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients–a pilot study. Nephrol Dial Transplant 22(12):3561–7
Svensson M, Schmidt EB, Jørgensen KA et al (2006) n-3 fatty acids as secondary prevention against cardiovascular events in patients who undergo chronic hemodialysis: a randomized, placebo-controlled intervention trial. Clin J Am Soc Nephrol 1(4):780–786
Poulia KA, Panagiotakos DB, Tourlede E et al (2011) Omega-3 fatty acids supplementation does not affect serum lipids in chronic hemodialysis patients. J Ren Nutr 21(6):479–484
Lok CE, Moist L, Hemmelgarn BR et al (2012) Effect of fish oil supplementation on graft patency and cardiovascular events among patients with new synthetic arteriovenous hemodialysis grafts: a randomized controlled trial. JAMA 307(17):1809–16
Daud ZA, Tubie B, Adams J et al (2012) Effects of protein and omega-3 supplementation, provided during regular dialysis sessions, on nutritional and inflammatory indices in hemodialysis patients. Vasc Health Risk Manag 8:187–195
Gharekhani A, Khatami MR, Dashti-Khavidaki S et al (2014) The effect of omega-3 fatty acids on depressive symptomsand inflammatorymarkers in maintenance hemodialysis patients: a randomized, placebo-controlled clinical trial. Eur J Clin Pharmacol 70:655–666
Kooshki A, Taleban FA, Tabibi H et al (2011) Effects of marine omega-3 fatty acids on serum systemic and vascular inflammation markers and oxidative stress in hemodialysis patients. Ann Nutr Metab 58(3):197–202
Hung AM, Booker C, Ellis CD et al (2015) Omega-3 fatty acids inhibit the up-regulation of endothelial chemokines in maintenance hemodialysis patients. Nephrol Dial Transplant 30(2):266–274
Bowden RG, Wilson RL, Gentile M et al (2007) Effects of omega-3 fatty acid supplementation on vascular access thrombosis in polytetrafluorethylene grafts. J Ren Nutr 17(2):126–131
Dashti-Khavidaki S, Gharekhani A, Khatami MR et al (2014) Effects of omega-3 fatty acids on depression and quality of life in maintenance hemodialysis patients. Am J Ther 21(4):275–287
Yevzlin AS, Chan MR, Becker YT et al (2010) “Venopathy” at work: recasting neointimal hyperplasia in a new light. Transl Res 156:216–25
He K, Song Y, Daviglus M et al (2004) Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation 109:2705–2711
Enns JE, Yeganeh A, Zarychanski R et al (2014) The impact of omega-3 polyunsaturated fatty acid supplementation on the incidence of cardiovascular events and complications in peripheral arterial disease: a systematic review and meta-analysis. BMC Cardiovasc Disord 14:70
Taraz M, Khatami MR, Gharekhani A et al (2012) Relationship between a pro- and anti-inflammatory cytokine imbalance and depression in hemodialysis patients. Eur Cytokine Netw 23:179–186
Chilcot J, Wellsted D, Farrington K (2010) Depression in end-stage renal disease: current advances and research. Semin Dial 23:74–82
Vaváková M, Ďuračková Z, Trebatická J (2015) Markers of oxidative stress and neuroprogression in depression disorder. Oxid Med Cell Longev 2015:898393
Chalon S (2006) Omega-3 fatty acids and monoamine neurotransmission. Prostaglandins Leukot Essent Fatty Acids 75:259–269
Farooqui AA, Ong WY, Horrocks LA (2006) Inhibitors of brain phospholipase A2 activity: their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders. Pharmacol Rev 58:591–620
Ewers B, Riserus U, Marckmann P (2009) Effects of unsaturated fat dietary supplements on blood lipids, and on markers of malnutrition and inflammation in hemodialysis patients. J Ren Nutr 19(5):401–411
Gharekhani A, Khatami MR, Dashti-Khavidaki S et al (2014) Effects of oral supplementation with omega-3 fatty acids on nutritional state and inflammatory markers in maintenance hemodialysis patients. J Ren Nutr 24(3):177–185
Young P, Lombi F, Finn BC et al (2011) “Malnutrition-inflammation complex syndrome” in chronic hemodialysis. Med B Aires 71(1):66–72
Gebauer SK, Psota TL, Harris WS et al (2006) n-3 fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. Am J Clin Nutr 83(Suppl 6):1526S–1535S
Acknowledgments
This work was supported by the National Natural Science Foundation of China (Grant No. 81000304) and the Hubei Provincial Natural Science Foundation of China (Grant No. 2010CDB00402).
Author’s contributions
Lei He and Ping Gao contributed to the study design, data analysis and manuscript. Meng-si Li, Mei Lin, and Tian-ya Zhao performed the article review, Meng-si Li and Mei Lin helped with the data analysis. All authors read and approved the final manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing of interests.
Rights and permissions
About this article
Cite this article
He, L., Li, Ms., Lin, M. et al. Effect of fish oil supplement in maintenance hemodialysis patients: a systematic review and meta-analysis of published randomized controlled trials. Eur J Clin Pharmacol 72, 129–139 (2016). https://doi.org/10.1007/s00228-015-1976-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-015-1976-y